Did You Know?

The most significant investment focus of Sam Altman, CEO of OpenAI and the driving force behind ChatGPT, is not AI, autonomous driving, or other trending technologies—but anti-aging technology.

Through concrete actions, Altman has demonstrated his belief that extending human lifespan will become the next revolutionary frontier following AI.

At the core of anti-aging technology lies cellular reprogramming—and today, the most advanced and mature cellular reprogramming technology is iPSC technology.

🔬 What Is iPSC Technology?

iPSC (induced pluripotent stem cell) technology enables somatic cells to be “reversed” into a state similar to embryonic stem cells, effectively rejuvenating cells and restoring their ability to regenerate any type of tissue or organ.

🔬 Why Store iPSCs?

✅ Disease Treatment Preparedness
Preserve healthy cells in advance for future personalized therapies targeting cardiovascular diseases, degenerative disorders, and more.

✅ Age Reversal & Regenerative Repair
Serve as a foundational platform for anti-aging and regenerative therapies, helping the body regain youthful vitality.

✅ Health Security for the Future
Build long-term health capital for yourself and your family—allowing health and care to be passed on across generations.

References:

Potential Breakthrough in Cell Reprogramming as OpenAI and Retro Biosciences Report 50x Pluripotency Marker Expression Gains

Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan